An experimental study on (131)I-CHIBA-1001: a radioligand for α7 nicotinic acetylcholine receptors.
OBJECTIVE
The α7 nicotinic acetylcholine receptors (nAChRs) play a vital role in the pathophysiology of neuropsychiatric diseases such as Alzheimer's disease and depression. However, there is currently no suitable positron emission tomography (PET) or Single-Photon Emission Computed Tomography (SPECT) radioligands for imaging α7 nAChRs in brain. Here our aim is to radiosynthesize a novel SPECT radioligand (131)I-CHIBA-1001 for whole body biodistribution study and in vivo imaging of α7 nAChRs in brain.


METHODS
(131)I-CHIBA-1001 was radiosynthesized by chloramine-T method. Different conditions of reaction time and temperature were tested to get a better radiolabeling yield. Radiolabeling yield and radiochemical purities of (131)I-CHIBA-1001 were analyzed by thin layer chromatography (TLC) and high-performance liquid chromatography (HPLC) system. Whole body biodistribution study was performed at different time points post injection of (131)I-CHIBA-1001 in KM mice. Monkey subject was used for in vivo SPECT imaging in brain.


RESULTS
The radiolabeling yield of (131)I-CHIBA-1001 reached 96% within 1.5∼2.0 h at 90∼95°C. The radiochemical purity reached more than 99% after HPLC purification. (131)I-CHIBA-1001 was highly stable in saline and fresh human serum in room temperature and 37°C separately. The biodistribution data of brain at 15, 30, and 60 min were 11.05±1.04%ID/g, 8.8±0.04%ID/g and 6.28±1.13%ID/g, respectively. In experimental SPECT imaging, the distribution of radioactivity in the brain regions was paralleled with the distribution of α7 nAChRs in the monkey brain. Moreover, in the blocking SPECT imaging study, the selective α7 nAChR agonist SSR180711 blocked the radioactive uptake in the brain successfully.


CONCLUSIONS
The CHIBA-1001 can be successfully radiolabeled with (131)I using the chloramine-T method. (131)I-CHIBA-1001 can successfully accumulate in the monkey brain and image the α7 acetylcholine receptors. (131)I-CHIBA-1001 can be a candidate for imagingα7 acetylcholine receptors, which will be of great value for the diagnosis and treatment of mental diseases.
Department of Nuclear Medicine, Peking University First Hospital, West District, Beijing, China.
Lei
L
Yin
Qian
Q
Zhao
Ling
L
Li
Su Lei
SL
Zhang
Xue Qi
XQ
Chen
Chao
C
Ma
Lei
L
Kang
Meng
M
Liu
Chun Li
CL
Zhang
Ping
P
Yan
Rong Fu
RF
Wang
D000818:Animals; D001921:Brain / Q000000981:diagnostic imaging / Q000378:metabolism; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000737:chemistry* / Q000378:metabolism*; D000882:Haplorhini; D006801:Humans; D007457:Iodine Radioisotopes / Q000737:chemistry*; D008024:Ligands; D008297:Male; D051379:Mice; D049268:Positron-Emission Tomography; D011485:Protein Binding; D051381:Rats; D014018:Tissue Distribution; D015899:Tomography, Emission-Computed, Single-Photon; D064569:alpha7 Nicotinic Acetylcholine Receptor / Q000378:metabolism*
D019086:Bridged Bicyclo Compounds, Heterocyclic; C533046:CHIBA 1001; D007457:Iodine Radioisotopes; D008024:Ligands; D064569:alpha7 Nicotinic Acetylcholine Receptor